| 15.7846 0.875 (5.87%) | 05-13 13:59 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 19.45 | 1-year : | 22.72 |
| Resists | First : | 16.65 | Second : | 19.45 |
| Pivot price | 15.04 |
|||
| Supports | First : | 13.28 | Second : | 11.19 |
| MAs | MA(5) : | 15.32  |
MA(20) : | 14.8 |
| MA(100) : | 14.01 |
MA(250) : | 0 | |
| MACD | MACD : | 0.5 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 48.2 |
D(3) : | 46.6 |
| RSI | RSI(14): 60.9 |
|||
| 52-week | High : | 26.91 | Low : | 10.27 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ OMDA ] has closed below upper band by 21.7%. Bollinger Bands are 19.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 15.01 - 15.08 | 15.08 - 15.16 |
| Low: | 14.13 - 14.21 | 14.21 - 14.28 |
| Close: | 14.79 - 14.91 | 14.91 - 15.03 |
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
Mon, 11 May 2026
Number of shareholders of Omada Health, Inc. – NASDAQ:OMDA - TradingView
Sat, 09 May 2026
Compared to estimates, Omada Health, Inc. (OMDA) Q1 earnings: A look at key metrics - MSN
Fri, 08 May 2026
CCORF Maintains Omada Health(OMDA.US) With Buy Rating, Raises Target Price to $24 - Moomoo
Fri, 08 May 2026
42% revenue surge as Omada Health (NASDAQ: OMDA) narrows Q1 2026 loss - Stock Titan
Fri, 08 May 2026
Omada Health reports 42% revenue growth in Q1 2026 earnings - MobiHealthNews
Fri, 08 May 2026
Omada Health (OMDA) Q1 2026 Earnings Transcript - AOL.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 59 (M) |
| Shares Float | 44 (M) |
| Held by Insiders | 2.1 (%) |
| Held by Institutions | 87.7 (%) |
| Shares Short | 3,660 (K) |
| Shares Short P.Month | 2,840 (K) |
| EPS | -0.35 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.93 |
| Profit Margin | -5 % |
| Operating Margin | 4.3 % |
| Return on Assets (ttm) | -3.3 % |
| Return on Equity (ttm) | -8.7 % |
| Qtrly Rev. Growth | 58 % |
| Gross Profit (p.s.) | 2.87 |
| Sales Per Share | 4.37 |
| EBITDA (p.s.) | -0.11 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 18 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | -45.16 |
| PEG Ratio | 0 |
| Price to Book value | 4.02 |
| Price to Sales | 3.6 |
| Price to Cash Flow | 51.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|